Sun Valley Research Center

Sun Valley Research Center

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sun Valley Research Center is a privately held, revenue-generating contract research organization (CRO) established in 2007. It differentiates itself through a deep community focus, serving a medically underserved population near the Mexican border, which aids in diverse patient recruitment for clinical trials. The company operates as a service provider, conducting trials for external sponsors in areas like anxiety, depression, bipolar disorder, ADHD, and migraines, with no proprietary technology or drug pipeline of its own. Its business model is built on providing clinical research services to the pharmaceutical and biotech industries.

NeurosciencePsychiatryImmunology

Technology Platform

Community-engaged clinical trial execution platform focused on recruiting diverse, underserved patient populations in a rural border region. Expertise in patient recruitment, retention, and trial management for studies involving medications, devices, and digital therapies.

Opportunities

The strong regulatory push for diverse clinical trial populations creates a major opportunity, as SVRC's community-focused model directly addresses this industry need.
Its established trust in an underserved border region provides a unique and scalable advantage in patient recruitment for CNS and other trials.

Risk Factors

Revenue is highly dependent on the fluctuating R&D pipelines of sponsor clients and concentrated in specific therapeutic areas.
Operational risks include maintaining regulatory compliance and data integrity, as any failure could severely damage its reputation and business.
Competition from larger, well-resourced CRO networks is significant.

Competitive Landscape

SVRC competes with large global CROs (like IQVIA, PPD) and networks of independent research sites. Its primary differentiation is its deep integration within a specific underserved community, offering sponsors access to a hard-to-reach patient demographic that is increasingly valuable for diverse trial enrollment.